Firmagon Evropska unija - hrvaščina - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degarelix - prostatske neoplazme - endokrinska terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

DECAPEPTYL DEPOT 3.75 mg/1 mL prašak i otapalo za suspenziju za injekciju Bosna in Hercegovina - hrvaščina - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

decapeptyl depot 3.75 mg/1 ml prašak i otapalo za suspenziju za injekciju

clinres farmacija d.o.o. - трипторелин - prašak i otapalo za suspenziju za injekciju - 3.75 mg/1 ml - 1 ml suspenzije za injekciju sadrži: 3,75 mg triptorelina (u obliku triptorelin acetata)